First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers

by Abou-Alfa, G.K, Ansaldi, C., Awada, A., Bestion, E.N, Decaens, T., Dreyer, C., Halfon, P., Harding, J.J, Kotecki, N., Menut, A., Merle, P., Mezouar, S., Paradis, V., Rachid, M., Raymond, E., Roth, G.
Published 2022

Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma

by Breder, V., Cheng, A.-L, Ducreux, M., Finn, R.S, Galle, P.R, Ikeda, M., Kaseb, A.O, Kim, T.-Y, Kudo, M., Li, D., Li, L., Lim, H.Y, Ma, N., Merle, P., Nicholas, A., Qin, S., Verret, W., Wang, Y., Zhu, A.X
Published 2022

A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real time quantitative PCR

by White, H., Deprez, L., Corbisier, P., Hall, V., Lin, F., Mazoua, S., Trapmann, S., Aggerholm, A., Andrikovics, H., Akiki, S., Barbany, G., Boeckx, N., Bench, A., Catherwood, M., Cayuela, J-M, Chudleigh, S., Clench, T., Colomer, D., Daraio, F., Dulucq, S., Farrugia, J., Fletcher, L., Foroni, L., Ganderton, R., Gerrard, G., Gineikienė, E., Hayette, S., El Housni, H., Izzo, B., Jansson, M., Johnels, P., Jurcek, T., Kairisto, V., Kizilors, A., Kim, D-W, Lange, T., Lion, T., Polakova, K.M, Martinelli, G., McCarron, S., Merle, P.A, Milner, B., Mitterbauer-Hohendanner, G., Nagar, M., Nickless, G., Nomdedéu, J., Nymoen, D.A, Leibundgut, E.O, Ozbek, U., Pajič, T., Pfeifer, H., Preudhomme, C., Raudsepp, K., Romeo, G., Sacha, T., Talmaci, R., Touloumenidou, T., Van der Velden, V.H.J, Waits, P., Wang, L., Wilkinson, E., Wilson, G., Wren, D., Zadro, R., Ziermann, J., Zoi, K., Müller, M.C, Hochhaus, A., Schimmel, H., Cross, N. C. P., Emons, H.
Published 2015